中文 | English
Return
Total: 52 , 1/6
Show Home Prev Next End page: GO
Author:( Yifan LUO)

2.Construction and expression of Runx1-shRNA expressiong plasmid.

Yifan CHEN ; Xiaoju TANG ; Fengming LUO

Journal of Biomedical Engineering 2014;31(4):837-841

4.Prevention of skin flap necrosis following eradicative operation of breast cancer

Guolin CHENG ; Fengjun WANG ; Yingwei XUE ; Yifan ZHANG ; Xiangqan LUO

Chinese Journal of Practical Surgery 2001;21(4):228-229

5.Experimental Study of Antidepressant Effects of Total Timosaponin

Lixiang REN ; Yifan LUO ; Shaojiang SONG ; Xia LI ; Yingliang WU

Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(01):-

6.Meta-analysis of effectiveness of Chinese materia medica as adjuvant therapy of antibacterial for pediatric mesenteric lymphadenitis

Yifan LUO ; Lixiang REN ; Xiaohong LI ; Mingyan JIANG

Drug Evaluation Research 2017;40(6):851-858

7.Summary of research methods for drug intestinal absorption

Yifan LUO ; Lixiang REN ; Xiaohong LI ; Yaoting SUN ; Mingyan JIANG

Drug Evaluation Research 2017;40(5):706-710

8.Clinical Dosage Regimens of Voriconazole Evaluated by Monte Carlo Simulation

Yifan LUO ; Lixiang REN ; Qi SUN ; Mingyan JIANG

China Pharmacy 2017;28(14):1907-1911

10.Synthesis, biological activity and molecular docking research of N-{(4-oxo-thiochroman-3-yl)phenyl-methyl}acetamide derivatives as α-glucosidase inhibitors.

Guan ZHOU ; Guochao LIANG ; Xiaoyan HAN ; Yifan ZHONG ; Yunfang DONG ; Xiaocong LUO ; Hongwei JIN ; Yali SONG

Acta Pharmaceutica Sinica 2016;51(1):93-9

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 52 , 1/6 Show Home Prev Next End page: GO